PHASEOLAMIN A HOPE IN THE TREATMENT OF DIABETES AND WEIGHT LOSS CURE

0,00 lei

somdn_product_page

(Downloads - 0)

Description

Sabina IONESCU, Radu IONESCU, Horia Sebastian ILIESCU, Camelia PETRESCU

The present work presents the action of inactivating pancreatic alpha amylase by the protein called Phaseolamin. Its chemical structure and mode of action in the human body are described, including the clinical study conducted by Jay Udani, MD – Assistant Clinical Professor, UCLA School of Medicine; Medical Director, Integrative Medicine Program, Northridge Hospital.

https://doi.org/10.58679/UTM40878

Reviews

There are no reviews yet.

Be the first to review “PHASEOLAMIN A HOPE IN THE TREATMENT OF DIABETES AND WEIGHT LOSS CURE”

Your email address will not be published. Required fields are marked *